Home » Newsletters » BioWorld Science

BioWorld Science

May 20, 2003

View Archived Issues

Schering sells stake in Oy Leiras to Nycomed

Pfizer to continue Pharmacia's collaboration with Vicuron

Diabact licenses Rapinyl to Kyowa Hakko

Xoma provides review of results for the first quarter

MCH antagonists in early development for obesity and related disorders at Schering-Plough

Schering-Plough researchers design new adenosine A2A antagonists for Parkinson's disease

Neurogen describes new NPY Y5 receptor modulators in recent patent literature

New IMPDH inhibitors, their preparation and use reported by Celltech R&D

Novel isoflavones with utility in hormone balance disorders, cancer, inflammation, etc.

New pyrrolidine-based FTase inhibitors under study at Wyeth

Applied Research Systems presents a novel series of prostanoid EP2/EP4 modulators

Antibacterial isoxazoles prepared and tested at AstraZeneca

Boehringer Ingelheim patent covers novel cytokine production inhibitors

Lipid-lowering effects of ezetimibe in hypercholesterolemia

Effective use of anidulafungin in patients with invasive candidiasis

Strong bactericidal activity found for oritavancin against clinical isolates

Aripiprazole is safe and improves psychotic symptoms in Alzheimer's dementia

New data on vardenafil reported at the American Geriatrics Society meeting

Milestone achieved in PROCARDIS consortium study

Bioenvision signs agreement with Penn for clofarabine

FDA approval to export DB-289 for malaria trial in Thailand

Advisory committee recommends approval of Xolair

Important European launch reported for Hepsera

Electrophysiological effects of drug selectively targeting I(Kur) in myocytes from AF patients

Butanediol esters as potential new bone resorption inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...